How long before surgery should you stop taking Mounjaro?

What NHS England and anaesthetic bodies actually say about pausing before surgery

The concern is not hypothetical. Tirzepatide's mechanism (acting on both GIP and GLP-1 receptors to slow gastric emptying) means solid food can remain in the stomach hours longer than expected, even when a patient believes they have fasted correctly. NHS England's weight-management-injections guidance explicitly advises telling your healthcare team, including your anaesthetist, before any surgical procedure. The NHS England page on weight-management injections reflects the professional consensus that this is a patient-safety issue, not a minor administrative note.

The Royal College of Anaesthetists and the Association of Anaesthetists have both published guidance recommending at least a one-week gap between the last dose of a once-weekly GLP-1 or dual-agonist injection and elective surgery. Because Mounjaro is a once-weekly injection, one missed dose broadly corresponds to that window, but some anaesthetic teams working with higher-risk patients or longer, more complex procedures ask for a two-week pause. The correct interval for you depends on your dose, your procedure, your surgical team's protocol and your individual clinical picture.

One misconception our prescribers hear fairly often is that a short same-day fast is enough to compensate for taking Mounjaro as normal. It is not. Delayed gastric emptying from tirzepatide persists beyond the last meal; a standard pre-operative fast does not reset it. The stomach may still hold content at the time of induction, and aspiration of stomach contents under anaesthesia carries serious risk. That is why the guidance exists, and why it should be taken seriously rather than managed around.

How to handle the pause in practice, and who decides

The practical steps are straightforward, but the decisions within them are clinical. First, tell your prescriber (whether that is a GP, hospital doctor or the prescriber at your online pharmacy) as soon as surgery is planned. They can document the pause formally and advise whether it affects your treatment plan. Second, tell your surgical team and anaesthetist at the pre-operative assessment stage. Do not wait until the admission day; some hospitals now ask patients directly about GLP-1 medicines at the initial booking call because the issue is that well recognised. For further detail on the recommended pre-operative pause window for Mounjaro, our dedicated page covers the specific timing considerations in full.

Third, plan the restart carefully. Restarting too soon after surgery is not advisable either, gastrointestinal motility may already be suppressed post-operatively, and the added effect of tirzepatide can compound nausea, poor oral intake and slow recovery. Again, your prescriber and surgical team should agree the restart timing. People wondering about the broader process of pausing or stopping Mounjaro can find more context on what to expect when doses are interrupted. Those who are pregnant or planning a family should also read our guidance on how long to stop Mounjaro before pregnancy, as the recommended pause for conception differs from the surgical context covered here.

If your surgery is urgent or unplanned, tell the medical team immediately that you have been taking Mounjaro and when your last dose was. The clinical team will factor that into their airway management decisions. There is no scenario in which withholding this information is the safer choice.

What happens to weight and treatment progress during a surgical pause

A week or two without Mounjaro will not erase months of progress. Tirzepatide's effects on appetite and weight are cumulative and reflect sustained use; a brief, planned pause is a routine part of responsible treatment, not a failure. Some people notice a return of appetite during the gap, which is normal. The trial evidence underpinning tirzepatide (including SURMOUNT-1, published in the New England Journal of Medicine, which followed participants over 72 weeks) shows that meaningful weight loss builds over months, and a short interruption does not negate that trajectory.

If you are partway through a dose-escalation schedule, your prescriber will advise whether to resume at your current dose or step back briefly to allow your system to readjust. For context on how Mounjaro produces its effects over time, the page on how long Mounjaro takes to work explains the typical timeline, and the detail on when weight loss tends to become noticeable may reassure people that a planned pause is part of safe treatment, not a setback.

Mounjaro is a prescription-only medicine assessed against a specific UK licence for weight management. Any adjustment to your schedule (including a surgical pause) should go through your prescriber, who reviews your care and holds the clinical picture. If you are not yet in a supervised programme and are considering treatment, starting with a free consultation means a GPhC-registered prescriber reviews your situation the same day and can account for any planned procedures from the outset.